The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

Using patient kidney biopsies, the team developed a new method to measure glycocalyx thickness, confirming that the layer is ...

Novo Nordisk has announced that the Food and Drug Administration (FDA) has approved semaglutide (Ozempic) to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular-related ...

The U.S. Food and Drug Administration (FDA) has approved Novo Nordisks (NYSE:NVO) Ozempic for reducing the risk of kidney ...

3 Cardiorenal protection of SGLT2i, GLP-1RAs, and DPP-4i The American Diabetes Association (ADA) recommends that SGLT2i and GLP-1RAs be used in combination with metformin as first-line initial therapy ...

These results demonstrate that we can capture thousands of atheroembolic particles during renal stenting procedures under protection, and that increasing captured particle counts greater than 60 ...

Natural polysaccharides (NPs) possess numerous health-promoting effects, such as liver protection, kidney protection, lung protection, neuroprotection, cardioprotection, gastrointestinal protection, ...

Sambalpur: The number of kidney patients is on the rise in Bargarh district due to use of pesticides in agriculture, ...

A recent study from the University of Hong Kong suggests that a newer type of diabetes drug, called sodium-glucose cotransporter 2 inhibitors (SGLT2i), may help protect the kidneys and lungs in people ...

In conclusion, even though low-dose dopamine may facilitate urine output and natriuresis, the overall benefit of this effect in renal protection (prevention of a rise in the serum creatinine ...